Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Living With Diabetes Photograph by Jinane Saad
Feature story
Feature story |
14 November 2019
Diabetes
Lebanon

Photo stories:  “Brave children with diabetes”

10 min
Challenges in Diabetes Management Jinane Saad Photograph by Jinane Saad
Feature story
Feature story |
12 November 2019
Diabetes

World Diabetes Day: “I had to ration the little insulin I had"

6 min
In the laboratory of the Mykolaiv Regional Center of Palliative Care and Integrated Services, with which MSF collaborates to treat patients with hepatitis C. Many of the tests required for the patients are performed here. Photograph by Aleksandr Glyadyelov
Feature story
Feature story |
25 July 2019
Hepatitis C
Ukraine

Generic medicines prove to be an affordable option in combating Ukraine’s hepatitis C epidemic

4 min
Thumbnail
Feature story
Feature story |
08 July 2019
Tropical & neglected diseases

A doctor's dream

"" Fanny Hostettler
Feature story
Feature story |
20 May 2019
Tropical & neglected diseases
South Sudan

Snakebite testimonials - in Agok, South Sudan

"" Fanny Hostettler
Feature story
Feature story |
20 May 2019
Tropical & neglected diseases
South Sudan

Antivenom, not frogs, needed to cure snakebite

6 min
So called “orange pills” (Amoxicillin), an antibiotic very popular among patients in Ahmed Shah Baba hospital in Kabul. Photograph by Doris Burtscher Photograph by Doris Burtscher
Feature story
Feature story |
16 April 2019
Intellectual property and trade

Secret medicine prices cost lives

5 min
XDR-TB_India_Patient_Bhakti_AtulLoke_Oct2016_MSF177949_3800px Atul Loke/Panos Pictures
Feature story
Feature story
India

Bhakti’s Story: Strength to Survive Drug-Resistant TB

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury